Latest Breaking News On - Anurag varshney - Page 1 : vimarsana.com

PRI working on spike protein of new Covid variant received from China: Balkrishna

With the spike in the number of the Covid sub-variant JN.1 cases across the country, Acharya Balkrishna said that the Patanjali Research Institute (PRI) has received the spike protein of the JN.1 variant Omicron from Sino Biological Lab based in China for research.  He further said that at a

Patanjali Research Foundation to study spike protein of Covid's new JN.1 variant

Inaugural ceremony for 2023 postgraduate batch held at Patanjali Ayurveda College

Baba Ramdev inaugurates international conference on 'Natural Medicine for Holistic Health'

Patanjali to spread Indian culture, medical practices in Korea, signs agreement with Daegu Hanny University

Expanding Breast Cancer Care for Indian Women

Tentative speakers and program schedule: “Expanding Breast Cancer Care for Indian

Launch of sustainable fashion brand - Lifoholic: Incredibly Indian

New Delhi [India], October 18 (ANI/PNN): The bustling Delhi-NCR witnessed the grand launch of Lifoholic - a sustainable fashion brand - at Lawn Bistro, Club Road, Noida Sector 15 A. The brand has been established by Prof (Dr) Shalini Verma who is successfully running two Make In India brands - Books33 (Green publishing house & Eco-friendly gift provider) and Samvaadshaala (India's first bi-lingual communication-based Ed-tech company) The Chief Guest of the launch event was Dr. Deepika Jain - Award-winning Celebrity Doctor, Mrs. India International, and Mrs. Delhi Global & Social Entrepreneur. She appreciated the endeavor to create awareness around much-needed sustainable processes in the fashion industry. With a carbon footprint accounting for over 10 per cent of the global greenhouse gas emissions, there's no secret that the fashion industry is also contributing towards destroying the environment. The other dignitaries present at the event were -Prof (Dr) Afrozul Haq, Vice Chancellor - H.A University, Imphal, Manipur; Prof Mangesh Gupte, IIT Bombay; Shri Amit Goel - Founder Eco - Prabandhan Shri Raghavendra Chaturvedi - Technocrat Consultant; Shri Hira Amit Rohilla - Founder Mitti Ki Khushboo Rashtriya Muhim; Ms Chiripal K Antara - Founder & Director Maya Weaves. Ms Smriti Agarwal - Owner Lawn Bistro. The best part of this launch event was that it was well-organized and well-coordinated by the young MBA sustainability champions - Vanshika Bhattacharya, Gauri Goel, Upasana Mandal, Simran Bhatia, Anurag Varshney, Nikhil Anand, Aditi Shriya, Ananya Nathani. The objective behind coming up with this sustainable fashion brand is to offer fashion that empowers the Indian artisan community, especially women, and at the same time saves the planet. The brand has adopted a collaborative, inclusive, and community-driven strategy to pinpoint the key issues confronting Mother Nature. And thereby promoting sustainability and a prosperous future for all. Answering the question, what motivated her to start Lifoholic Sustainable Fashion Brand. She says - I always believed that India is not only the land of rich diversified culture but also an affluent fabric-based fashion hub. Brand Lifoholic is an answer to leverage our opulent fashion products prepared indigenously by our artisan community. Even the tagline of our brand is 'Incredibly Indian'. The three guiding principles of Lifoholic are - Make In India, maximum style, and minimal harm to Mother Nature. The items are handcrafted utilizing the best materials and textiles that are manufactured in environmentally friendly ways and sourced directly from artisans from the length and breadth of the country. This story has been provided by PNN. ANI will not be responsible in any way for the content in this article. (ANI/PNN)

How Modi's Hindutva irrationality makes India's war on Covid-19 even more difficult

Ramdev and Narendra Modi at a yoga event in Delhi in 2014. | Adnan Abidi/Reuters Earlier this month, the Ayush ministry offered detailed advice on how to build one’s immunity during the “Covid-19 Crisis”. To help ward off the dreaded disease, the ministry listed a series of specific recommendations, including, “Apply Sesame oil/Coconut oil/Cow Ghee... in both the nostrils in morning and evening.” However, if one didn’t like putting stuff in one’s nose, the ministry offered an alternative: “Take 1 table spoon sesame oil or coconut oil in the mouth. Do not drink, swish in the mouth for 2 to 3 minutes and spit it off followed by warm water rinse [sic]”.

Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August

Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients. 2-DG has been studied in more than 200 clinical trials for the treatment of various cancers globally. New Delhi: With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals and involving 220 patients may continue till August.

Phase-3 clinical trials for 2-DG may continue till Aug: Registry data

With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals and involving 220 patients may continue till August. The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients. While 2-DG has been studied in more than 200 clinical trials for the treatment of various cancers globally, trials to use it as a COVID-19 drug are apparently being done in India only and incidentally, a strong case for its therapeutic use against the novel coronavirus was made in a study paper last year that had Patanjali Research Institute's Acharya Balkrishna as the lead author.